FierceBiotech 22 abr 2026 Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
FierceBiotech 15 abr 2026 Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech 23 mar 2026 Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
FierceBiotech 20 mar 2026 Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
FierceBiotech 18 feb 2026 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal